-
1
-
-
84908242061
-
-
Xiao, Y.; Sun, Z.; Guo, H.; Kwon, O. Beilstein J. Org. Chem. 2014, 10, 2089 - 2121
-
(2014)
Beilstein J. Org. Chem.
, vol.10
, pp. 2089-2121
-
-
Xiao, Y.1
Sun, Z.2
Guo, H.3
Kwon, O.4
-
2
-
-
84863619322
-
-
Georg Thieme Verlag: Stuttgart
-
Fan, Y. C.; Kwon, O. In Science of Synthesis: Asymmetric Organocatalysis; List, B.; Maruoka, K., Eds.; Georg Thieme Verlag: Stuttgart, 2012; Vol. 1, pp 723 - 782.
-
(2012)
Science of Synthesis: Asymmetric Organocatalysis
, vol.1
, pp. 723-782
-
-
Fan, Y.C.1
Kwon, O.2
List, B.3
Maruoka, K.4
-
4
-
-
0034867881
-
-
Lu, X.; Zhang, C.; Xu, Z. Acc. Chem. Res. 2001, 34, 535 - 544
-
(2001)
Acc. Chem. Res.
, vol.34
, pp. 535-544
-
-
Lu, X.1
Zhang, C.2
Xu, Z.3
-
6
-
-
84891583906
-
-
John Wiley & Sons, Inc. Hoboken, NJ
-
Leclerc, E. In Chemical Synthesis of Nucleoside Analogues; Merino, P., Ed.; John Wiley & Sons, Inc.: Hoboken, NJ, 2013; pp 535 - 604.
-
(2013)
Chemical Synthesis of Nucleoside Analogues
, pp. 535-604
-
-
Leclerc, E.1
Merino, P.2
-
7
-
-
0030974493
-
-
Zhu, G.; Chen, Z.; Jiang, Q.; Xiao, D.; Cao, P.; Zhang, X. J. Am. Chem. Soc. 1997, 119, 3836 - 3837
-
(1997)
J. Am. Chem. Soc.
, vol.119
, pp. 3836-3837
-
-
Zhu, G.1
Chen, Z.2
Jiang, Q.3
Xiao, D.4
Cao, P.5
Zhang, X.6
-
8
-
-
33745941049
-
-
Wilson, J. E.; Fu, G. C. Angew. Chem., Int. Ed. 2006, 45, 1426 - 1429
-
(2006)
Angew. Chem., Int. Ed.
, vol.45
, pp. 1426-1429
-
-
Wilson, J.E.1
Fu, G.C.2
-
10
-
-
33846917246
-
-
Wallace, D. J.; Sidda, R. L.; Reamer, R. A. J. Org. Chem. 2007, 72, 1051 - 1054
-
(2007)
J. Org. Chem.
, vol.72
, pp. 1051-1054
-
-
Wallace, D.J.1
Sidda, R.L.2
Reamer, R.A.3
-
12
-
-
54849416798
-
-
Voituriez, A.; Panossian, A.; Fleury-Bregeot, N.; Retailleau, P.; Marinetti, A. J. Am. Chem. Soc. 2008, 130, 14030 - 14031
-
(2008)
J. Am. Chem. Soc.
, vol.130
, pp. 14030-14031
-
-
Voituriez, A.1
Panossian, A.2
Fleury-Bregeot, N.3
Retailleau, P.4
Marinetti, A.5
-
14
-
-
77953662039
-
-
Xiao, H.; Chai, Z.; Zheng, C.-W.; Yang, Y.-Q.; Liu, W.; Zhang, J.-K.; Zhao, G. Angew. Chem., Int. Ed. 2010, 49, 4467 - 4470
-
(2010)
Angew. Chem., Int. Ed.
, vol.49
, pp. 4467-4470
-
-
Xiao, H.1
Chai, Z.2
Zheng, C.-W.3
Yang, Y.-Q.4
Liu, W.5
Zhang, J.-K.6
Zhao, G.7
-
15
-
-
79951535933
-
-
Han, X.; Wang, Y.; Zhong, F.; Lu, Y. J. Am. Chem. Soc. 2011, 133, 1726 - 1729
-
(2011)
J. Am. Chem. Soc.
, vol.133
, pp. 1726-1729
-
-
Han, X.1
Wang, Y.2
Zhong, F.3
Lu, Y.4
-
17
-
-
0037414272
-
-
Wang, J.-C.; Ng, S.-S.; Krische, M. J. J. Am. Chem. Soc. 2003, 125, 3682 - 3683
-
(2003)
J. Am. Chem. Soc.
, vol.125
, pp. 3682-3683
-
-
Wang, J.-C.1
Ng, S.-S.2
Krische, M.J.3
-
18
-
-
0346789527
-
-
Wang, J.-C.; Krische, M. J. Angew. Chem., Int. Ed. 2003, 42, 5855 - 5857
-
(2003)
Angew. Chem., Int. Ed.
, vol.42
, pp. 5855-5857
-
-
Wang, J.-C.1
Krische, M.J.2
-
21
-
-
84878657077
-
-
Peng, X.-M.; Damu, G. L. V.; Zhou, C.-H. Curr. Pharm. Des. 2013, 19, 3884 - 3930
-
(2013)
Curr. Pharm. Des.
, vol.19
, pp. 3884-3930
-
-
Peng, X.-M.1
Damu, G.L.V.2
Zhou, C.-H.3
-
22
-
-
84926675318
-
-
Pangal, A.; Gazge, M.; Mane, V.; Shaikh, J. A. Int. J. Pharm. Res. Bio-Sci. 2013, 2, 168 - 194
-
(2013)
Int. J. Pharm. Res. Bio-Sci.
, vol.2
, pp. 168-194
-
-
Pangal, A.1
Gazge, M.2
Mane, V.3
Shaikh, J.A.4
-
23
-
-
84859577362
-
-
Kontogiorgis, C.; Detsi, A.; Hadjipavlou-Litina, D. Expert Opin. Ther. Pat. 2012, 22, 437 - 454
-
(2012)
Expert Opin. Ther. Pat.
, vol.22
, pp. 437-454
-
-
Kontogiorgis, C.1
Detsi, A.2
Hadjipavlou-Litina, D.3
-
26
-
-
79959399753
-
-
Gladiali, S.; Alberico, E.; Junge, K.; Beller, M. Chem. Soc. Rev. 2011, 40, 3744 - 3763
-
(2011)
Chem. Soc. Rev.
, vol.40
, pp. 3744-3763
-
-
Gladiali, S.1
Alberico, E.2
Junge, K.3
Beller, M.4
-
27
-
-
84926610400
-
-
note
-
As a solid, phosphepine 4 is stable to air: after exposure to air for 2 months, no phosphine oxide was detected upon analysis by 31P NMR spectroscopy; as a solution in toluene open to air, no phosphine oxide was evident after 12 h.
-
-
-
-
29
-
-
84926684061
-
-
note
-
A negative ee value signifies that the major annulation product is the enantiomer of A.
-
-
-
-
30
-
-
84926686083
-
-
note
-
Notes: For entry 1 of Table 1, the ee of the product is constant throughout the annulation.
-
-
-
-
31
-
-
84926615130
-
-
note
-
A preliminary attempt to apply our standard conditions to the corresponding synthesis of a hydrindane was not successful.
-
-
-
-
32
-
-
84926670419
-
-
note
-
For the determination of the relative and absolute configuration of the various reaction products, see the Supporting Information.
-
-
-
-
33
-
-
84926643424
-
-
note
-
In contrast, α,β-unsaturated esters were not suitable reaction partners in Krische's P(n -Bu)3-catalyzed intramolecular [3+2] annulation (ref 8a).
-
-
-
-
34
-
-
84926616876
-
-
note
-
To the best of our knowledge, there has been only one report of an intramolecular Lu annulation of a substrate wherein the olefin is trisubstituted (ref 8b).
-
-
-
-
36
-
-
84926611830
-
-
note
-
Abilify is an example of a bioactive compound that includes a quinolin-2-one subunit.
-
-
-
-
37
-
-
84926638723
-
-
note
-
We are aware of one previous report of kinetic resolution in a Lu [3+2] annulation, an intermolecular coupling with s ∼ 1.3 (ref 5b).
-
-
-
-
38
-
-
84926652475
-
-
note
-
Notes: The ee of the product is independent of the enantiomeric purity of the allene.
-
-
-
-
39
-
-
84926673680
-
-
note
-
The reaction of an enantioenriched allene with an achiral phosphine led to racemic product.
-
-
-
-
40
-
-
84926672356
-
-
note
-
We have examined the rate law, employing enantioenriched (the more reactive enantiomer), rather than racemic, starting material, to avoid complications due to the divergent reactivity of the two enantiomers. The rate law is first order in the catalyst and ∼first order in the substrate. No racemization of the enantioenriched substrate is observed during the course of these kinetics studies.
-
-
-
-
41
-
-
84926637083
-
-
note
-
This is consistent with Krische's observations for a P(n -Bu)3-catalyzed intra molecular cycloaddition (ref 8b) and stands in contrast to the stepwise pathway that has been suggested for inter molecular annulations (ref 7).
-
-
-
|